Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
Abroad (travel likely)RecruitingPHASE2
Conditions
Myelodysplastic/Myeloproliferative Neoplasm · Primary Myelofibrosis · Secondary Myelofibrosis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Contact: Principal Investigator (Rachel Salit, MD)
Study leads
Rachel Salit, MD
Principal Investigator
Fred Hutch/University of Washington Cancer Consortium